Yelp, Medtronic Get Praised by Analysts, Not the Case for GameStop

In Friday's Analysts' Actions, Wall Street firms are giving positive remarks on Yelp (YELP) and Medtronic (MDT) while another firm isn't too happy about GameStop (GME).
Author:
Publish date:

In Friday's Analysts' Actions, Wall Street firms are giving positive remarks on Yelp (YELP) and Medtronic (MDT) while another firm isn't too happy about GameStop (GME). RBC Capital Markets gave Yelp a boost to OUTPERFORM from SECTOR PERFORM with a $42 price target. Analysts said 'We continue to see unique core and strategic value' in the company. Yelp is a leader they add, in helping to connect small businesses to consumers and, its app rankings have gone up. Given these reasons, analysts are bullish. In another note, Goldman Sachs added Medtronic to 'Americas Conviction BUY List' and lifted its price target to $90 from $87. Here's why: improving end-markets, new product launches and financial flexibility. Overall, analysts said it has the strongest fundamentals the company has seen in nearly a decade. The firm added that investors shouldn't overlook these strengths. Meanwhile, analysts are not too optimistic on GameStop. KeyBanc Capital Markets dropped its rating to SECTOR WEIGHT from OVERWEIGHT. The firm sees some risks as physical software sales have been struggling to grow. On top of this, it appears that the company has 'very little profitability in digital.' TheStreet's U-Jin Lee reports in New York.